[Form 4] Cinemark Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Melissa Thomas, EVP and Chief Financial Officer of Cinemark Holdings, Inc. (CNK), reported an automatic sale of common stock under a Rule 10b5-1 trading plan. On 08/15/2025 she disposed of 7,200 shares at a weighted average price of $25.17 per share, leaving her with 203,768 shares beneficially owned. The Form 4 notes the 10b5-1 plan was adopted on September 4, 2024, so the sale occurred pursuant to pre-established instructions. The filing was signed by attorney-in-fact Michael Cavalier on 08/18/2025.

Positive

• Sale executed under a documented Rule 10b5-1 plan, adopted 09/04/2024, indicating pre-planned disposition
• Reporting person retains substantial ownership with 203,768 shares beneficially owned after the sale
• Form 4 filed and signed by attorney-in-fact (Michael Cavalier) on 08/18/2025, demonstrating disclosure compliance

Negative

• Insider sale of 7,200 shares could be perceived negatively by some investors despite being pre-planned
• Transaction reduces insider’s holdings, although the remaining stake is still substantial

Insights

Financial Analyst

TL;DR: Routine, pre-planned insider sale; modest reduction in holdings with no disclosed company-specific catalyst.

The disclosed 7,200-share sale at a weighted average $25.17 is explicitly identified as executed under a 10b5-1 plan adopted 09/04/2024, which typically signals pre-scheduled disposition rather than a reaction to material nonpublic information. The remaining beneficial ownership of 203,768 shares keeps the CFO materially invested in the company, suggesting alignment with shareholder interests. From a market-impact perspective, the transaction size appears modest relative to typical public float, and no additional transactions or derivative activity are reported.

Corporate Governance Expert

TL;DR: Proper procedural disclosure; sale executed via 10b5-1 plan and properly reported.

The filing discloses necessary governance signals: the relationship of the reporting person (EVP, CFO), the 10b5-1 plan adoption date, and an attorney-in-fact signature dated 08/18/2025. These elements align with standard compliance practices for insider trading reporting. No amendments or additional insider arrangements are disclosed. The filing does not indicate any unusual timing or regulatory exceptions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomas Melissa

(Last) (First) (Middle)

3900 DALLAS PARKWAY

(Street)

PLANO TX 75093

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cinemark Holdings, Inc. [ CNK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		S		7,200(1)	D	$25.17(2)	203,768	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported on this Form 4 occured automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2024.

2. The reported price per share is the weighted average sale price for the shares.

	/s/ Michael Cavalier attorney-in-fact	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Melissa Thomas report for Cinemark (CNK)?

She reported a sale of 7,200 shares of Cinemark common stock on 08/15/2025.

At what price were the CNK shares sold by the reporting person?

The shares were sold at a weighted average price of $25.17 per share.

Was the sale by the Cinemark CFO part of a pre-established trading plan?

Yes. The Form 4 states the sale occurred automatically under a Rule 10b5-1 trading plan adopted on 09/04/2024.

How many Cinemark shares does the reporting person own after the sale?

Following the reported transaction the reporting person beneficially owned 203,768 shares.

Who signed the Form 4 filing for this transaction?

The Form 4 was signed by attorney-in-fact Michael Cavalier on 08/18/2025.